Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corallopyronin A: antimicrobial discovery to preclinical development.
Krome AK, Becker T, Kehraus S, Schiefer A, Gütschow M, Chaverra-Muñoz L, Hüttel S, Jansen R, Stadler M, Ehrens A, Pogorevc D, Müller R, Hübner MP, Hesterkamp T, Pfarr K, Hoerauf A, Wagner KG, König GM. Krome AK, et al. Among authors: becker t. Nat Prod Rep. 2022 Sep 21;39(9):1705-1720. doi: 10.1039/d2np00012a. Nat Prod Rep. 2022. PMID: 35730490 Review.
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A.
Krome AK, Becker T, Kehraus S, Schiefer A, Steinebach C, Aden T, Frohberger SJ, López Mármol Á, Kapote D, Jansen R, Chaverra-Muñoz L, Hübner MP, Pfarr K, Hesterkamp T, Stadler M, Gütschow M, König GM, Hoerauf A, Wagner KG. Krome AK, et al. Among authors: becker t. Pharmaceutics. 2020 Nov 18;12(11):1105. doi: 10.3390/pharmaceutics12111105. Pharmaceutics. 2020. PMID: 33217948 Free PMC article.
In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A.
Becker T, Krome AK, Vahdati S, Schiefer A, Pfarr K, Ehrens A, Aden T, Grosse M, Jansen R, Alt S, Hesterkamp T, Stadler M, Hübner MP, Kehraus S, König GM, Hoerauf A, Wagner KG. Becker T, et al. Pharmaceutics. 2022 Aug 9;14(8):1657. doi: 10.3390/pharmaceutics14081657. Pharmaceutics. 2022. PMID: 36015283 Free PMC article.
Mesoporous Silica as an Alternative Vehicle to Overcome Solubility Limitations.
Becker T, Heitkötter J, Krome AK, Schiefer A, Pfarr K, Ehrens A, Grosse M, Sandargo B, Stammberger I, Stadler M, Hübner MP, Kehraus S, Hoerauf A, Wagner KG. Becker T, et al. Pharmaceutics. 2024 Mar 12;16(3):386. doi: 10.3390/pharmaceutics16030386. Pharmaceutics. 2024. PMID: 38543280 Free PMC article.
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H; COVID-19 Prevention Network (CoVPN). Fisher LH, et al. JAMA Netw Open. 2024 May 1;7(5):e2412835. doi: 10.1001/jamanetworkopen.2024.12835. JAMA Netw Open. 2024. PMID: 38780941 Free PMC article.
2,380 results